Recapping Live Coverage, Interviews, and News From the 2024 American Academy of Dermatology Annual Meeting

Yesterday was the conclusion of the eventful 2024 American Academy of Dermatology (AAD) Annual Meeting. Dermatology Times editors were on site in San Diego for all 5 days of the CME conference providing you with the latest updates live from the conference floor.

In total, we spoke with nearly 40 different experts in dermatology. We covered several late-breaking clinical research updates, award-winning poster presentations, and provided detailed insights from numerous conference sessions.

Not only did we cover the AAD's annual meeting, but we also provided coverage and insights from 2 meetings hosted in conjunction: the 20th Annual Skin of Color Society (SOCS) Scientific Symposium and the 36th Annual Pre-AAD Meeting of the Society for Pediatric Dermatology.

With so much to unpack (from the meeting and from suitcases, of course), we have compiled our coverage into a comprehensive recap to provide you with an overview of everything you missed or need to know.

Acne and Rosacea

Acne and Rosacea Pearls With Jim Del Rosso, DO, FAAD

The American Acne and Rosacea Society welcomed Del Rosso as its new president and he shared key takeaways from his AAD sessions.

Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of Acne

Gallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies.

Addressing Antibiotic Stewardship and Acne Guidelines at AAD

Naiem Issa, MD, PhD, emphasized the importance of increased awareness regarding antibiotic stewardship among dermatologists, as well as the recently updated acne guidelines.

Aesthetic Dermatology

Trends in Cosmeceuticals and Nutraceuticals: Exosomes and Adaptogens Take Center Stage

Discover the science behind cosmeceutical advancements and the importance of staying informed for enhanced patient care with Zoe Diana Draelos, MD.

Late-Breaking Phase 2b Data Showed Efficacy of Injectable Polidocanol for Submental Fat Reduction

The injectable polidocanol exhibited high efficacy, quicker onset of benefit, reduced downtime, and fewer side effects lasting longer than 30 days.

Jill Waibel, MD, FAAD: Innovations in Laser Modalities for the Treatment of Scars

Waibel shared pearls in laser therapy and other scar treatment modalities in her talks at AAD.

Cheri Frey, MD, FAAD: Exploring Cosmeceutical Ingredients and Their Role in Skin Health

Frey discussed the role of various cosmeceuticals and ingredients in benefitting the skin health of patients, as well as insights into pairing OTC products with Rx.

Atopic Dermatitis and Eczema

Tapinarof Cream 1% Efficacious in Adults and Children With Skin of Color Down to 2 Years With AD

New data was presented at the American Academy of Dermatology Annual Meeting in San Diego, California.

The Impact of Atopic Dermatitis on Childhood Growth: Insights from the PEDISTAD Study

The international observational study aims to understand how moderate to severe AD affects children under 12 years of age, particularly in terms of height, weight, and BMI.

Late-Breaking Data: Long-Term Safety and Efficacy of Delgocitinib Cream for Chronic Hand Eczema

Melinda Gooderham, MSc, MD, FRCPC, provided insights into the significance of the DELTA 3 extension data presented at AAD 2024.

Device and Drug Updates

Science Behind OTC Products to Enhance Care for Atopic Dermatitis, Acne, and Sun Protection

Menes Kizoulis shared key highlights from the research conducted alongside leading dermatologists, like Alan Irvine, MD, DSc, and Patricia Farris, MD, MS.

When Comparing JAKs to Immunomodulators, Analysis Revealed Equal or Lower Incidence Rates For Major Adverse Events

The third-place poster provided insights into the safety profile of JAK inhibitors.

How Can Patients Benefit From New Device, TruFacial?

Founder Dina El-Sherif, MBA, gave an in-depth overview of the at-home facial rejuvenation device and its 3-step process at AAD 2024.

Diversity, Equity, and Inclusion

SLIDESHOW: A Walk Through the SOCS Virtual Poster Hall

The 20th Annual Skin of Color Society Scientific Symposium featured diverse research including studies on traction alopecia among individuals with religious head coverings, challenges in color-matching universal tinted sunscreens, dermatologic disparities in American Indian/Alaskan Native populations, and more.

Navigating the Path to Equity: Insights from Aletha Maybank, MD, MPH

"We cannot do health equity outside of an institution unless we figure out how to get our own house in order," the AMA leader said.

American Academy of Dermatology Upholds Diversity Policies in Face of Anti-DEI Proposal

A vote during the annual meeting will keep DEI initiatives in place and members are awaiting news on what those initiatives will look like.

Advocating for Increased Representation of Women in Dermatology

The Bristol Myers Squibb-hosted event brought together a panel of leading women in dermatology to discuss the challenges they've faced and how women can support each other.

Hair Loss

Award-Winning Research on Hair Loss Consensus Highlighted at Annual Meeting

The poster shares results form consensus research on using LODM for hair loss.

What’s New in Hair Loss Therapies and Exosomes?

Ronda Farah, MD, FAAD, reviews top hair loss pearls from her 5 sessions at AAD 2024.

Hidradenitis Suppurativa

HS Excision Clinical Pearls Discussed at AAD Annual Meeting

How can you improve excision care for your patients with hidradenitis suppurativa? Ashley Nicole Elsensohn, MD, MPH, FAAD, shared clinical pearls at the AAD Annual Meeting.

Late-Breaking Data: Lutikizumab Shows Positive Results in Difficult-to-Treat HS After Failed TNF Therapy

Alexandra Kimball, MD, FAAD, reviews late-breaking data at AAD on lutikizumab for hidradenitis suppurativa.

Anticipated FDA Approval of Bimekizumab for HS: Insights From Investigator Christopher Sayed, MD

The phase 3 studies, BE HEARD I and BE HEARD II, showed significant improvements in skin pain over the 48-week period.

Surgical Procedures to Consider for Hidradenitis Suppurativa

Maria Aleshin, MD, FAAD, presented surgical procedures for HS that can be performed in the office.

Maternal Hidradenitis Suppurativa Linked to Increased Risk of Childhood Morbidity

Furthermore, prenatal exposure to hyperandrogenism, a hormonal imbalance characteristic of HS, may influence the health outcomes of boys and girls differently.

Hot Topics

How is Artificial Intelligence Growing Up?

Joseph Zabinski, PhD, MEM, of OM1, shares insights at AAD into how artificial intelligence can mature and be a positive tool for disease detection.

Navigating Delusional Infestations in Dermatology

Jenny Murase, MD, said the average dermatologist manages 2-3 patients with delusional infestations every 5 years. Learn what to expect and how to manage it with empathy.

Updates on Benzene in Benzoyl Peroxide Products at AAD

Christopher Bunick, MD, PhD, presented updates and new data on the recent news of benzene found in benzoyl peroxide products.

Ichthyosis

Managing Ichthyosis in the General Dermatology Office

Christopher Bunick, MD, PhD, provides tips for the general dermatologist to treat ichthyosis and shares data on TMB-001 in development for ichthyosis.

Alan Mendelsohn, MD, Shares Insights Into Congenital Ichthyosis Patient Care and the Development of TMB-001

The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.

Itch

Peter Lio, MD, FAAD: Navigating Dietary Triggers in Urticaria and Atopic Dermatitis

Lio delves into his American Academy of Dermatology Annual Meeting session, "Dietary Triggers and Modifications of Common Dermatologic Conditions: An Evidence Based Approach."

Adam Friedman, MD, FAAD: Exploring the Utilization of Immunomodulators as Therapeutic Interventions in Chronic Spontaneous Urticaria

In addition to recapping key highlights from his session, Friedman discusses what is new or upcoming in dermatology that most excites him.

Red, Itchy, And AD Until Proven Otherwise

Raj Chovatiya, MD, PhD, delved into the conditions that could be red, itchy, and not atopic dermatitis. He explained the importance of knowing characteristics for various inflammatory conditions.

Advances in Itch: Brian S. Kim, MD, Shares Insights and Treatment Tips

Kim, who received the Marion B. Sulzberger Award at the 2024 American Academy of Dermatology Annual Meeting, discussed itch research an implications for clinical practice.

Patients, Practice, and Finance

Conquering the Dermatology Board Exam: Tips From Raj Chovatiya, MD, PhD

Chovatiya acknowledged the common sentiment among residents who, despite dedicating significant time to studying and working during residency, may feel unprepared.

Tips for Approaching Challenging Interactions and Communications With Patients

Jason S. Reichenberg, MD, MBA, FAAD, shares tips for improving interactions and communications at the 2024 AAD Annual Meeting.

Lessons From Boston Medical Center’s Coping Clinic

Dermatologists are able to connect pediatric patients to psychology clinicians for multidisciplinary care under one roof.

Navigating Finances in Dermatology: Top 5 Considerations for Dermatologists

In an exclusive interview with Gary Dudzik, he shared top 5 considerations dermatology clinicians should have when choosing financial services for their practices and overall financial goals.

Peter Lio, MD, FAAD: Minimizing Pain and Addressing Systemic Malignancy With Alternative Therapies

Lio discussed his sessions at AAD, including addressing systemic malignancies with alternative or adjunctive therapies and the importance of minimizing pain in dermatology procedures.

Pediatric Dermatology

Leveraging the Power of Shared Decision Making in Pediatric Dermatology

Kelly M. Cordoro, MD, shared tips on implementing shared decision making in pediatric dermatology dermatology at the annual conference.

Evolution and Innovation in Treating Psoriasis in Pediatric Patients

April W. Armstrong, MD, MPH, shared treatment insights with attendees at the 36th Annual Pre-AAD Meeting of the Society for Pediatric Dermatology.

Lawrence Eichenfield, MD: Outlining Late-Breaking INTEGUMENT-PED Data for Roflumilast in Pediatric Patients

Eichenfield discusses the late-breaking data on roflumilast cream 0.05% in the pediatric patient population and its implications.

Discussing Late-Breaking INTEGUMENT-PED Data With Arcutis' Chief Medical Officer, Patrick Burnett, MD, PhD, FAAD

Burnett recently spoke with Dermatology Times to discuss the background, methods, and findings of the late-breaking INTEGUMENT-PED data, as well as its potential real-world and clinical implications.

Lisa Swanson, MD, FAAD: Clinical Pearls and Updates for Pediatric Dermatology

Swanson shared updates: a look ahead and what's in store for pediatric dermatology.

Catching Up With Karan Lal, DO, MS FAAD

In between sessions, Lal shared his favorite pearls from AAD, a recent challenging pediatric case in his practice, the significance of LinkedIn, and more.

Pigmentation

Combining Surgical Precision With Immunological Innovation in Vitiligo Treatment

Maggi Ahmed, MD, PhD, demonstrated superior pigmentation outcomes and reduced CD8+ T cell numbers in her recent research results.

Late-Breaking Data: Upadacitinib for Vitiligo Achieves Skin Repigmentation Through Week 52

Iltefat Hamzavi, MD, reviews late-breaking data at AAD on upadacitinib as monotherapy.

Environmental Factors Affecting Pigmentation And The Skin Exposome

Arianne Shadi Kourosh, MD, MPH, FAAD, shared pearls on environmental factors that can impact skin aging and pigmentation including visible light, IR radiation, location, and pollution.

Prurigo Nodularis

Late-Breaking Data: Long-Term Safety and Efficacy of Largest Prurigo Nodularis Study Ever Conducted

Shawn Kwatra, MD, presented late-breaking data at AAD 2024 on the largest prurigo nodularis and nemolizumab clinical trial, OLYMPIA.

Late-Breaking Data: Povorcitinib Significantly Improves Itch and Lesions in Prurigo Nodularis

Shawn Kwatra, MD, shared positive updates on phase 2 oral povorcitinib for prurigo nodularis.

Psoriasis

Making Psoriasis Treatment More Accessible: LITE Study Shows Home Phototherapy Success

In an AAD late-breaking research session, Joel Gelfand, MD, MSCE, FAAD, presented in-depth results of the LITE Study.

Johnson & Johnson Reveals Promising Results for JNJ-2113 in FRONTIER 2 Study

Lloyd Miller, MD, PhD, delves into the new data demonstrating high rates of skin clearance over 52 weeks in adults with moderate to severe plaque psoriasis.

Sharing Innovations in Psoriasis Biologics and Uplifting Women in Dermatology

Mona Shahriari, MD, presented real-world data on the efficacy of IL-23 inhibitors for psoriasis, as well as shared her advice from the Bristol Myers Squibb Women's Connection Forum.

Skin Cancer

Serving Those Who Serve Our Communities: Melanoma in Veterans and Firefighters

Rebecca Hartman, MD, MPH, FAAD, and Christine Kannler, MD, FAAD, took a deep dive into considerations and pearls to treat patients who have been exposed to extreme heat and chemicals in the line of duty.

To keep up to date with future conference coverage updates, be sure to subscribe to Dermatology Times eNewsletters.